Your session is about to expire
← Back to Search
Test Product: JDS-HF3.0 Capsules for Hot Flashes
Study Summary
This trial looks at a dietary supplement to see if it safely reduces hot flashes in menopausal women.
- Hot Flashes
- Postmenopausal Disorders
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have participated in another research study and received a test product within the last 28 days or longer if the previous test product could affect your eligibility or outcomes in this study.You have smoked within the past 3 years.Your BMI is between 18.5 and 34.9 kg/m2, inclusive.You are compliant with the parameters of this study, have given consent willingly, can comprehend and read all survey materials, and are capable of executing associated research activities.You have an MRS score of 2 or more at screening and baseline.You have experienced menopausal symptoms in the last 6 months.You experience an average of five or more moderate to severe hot flashes and night sweats on a daily basis for 7 days.You are a healthy menopausal woman aged between 40 and 65.You have had a menstrual period at least 6 months before the screening.You possess normal or investigator-approved vital signs (blood pressure and heart rate) at the screening stage.You must abstain from treatments for hot flashes and other menopausal symptoms.You cannot use any vaginal medications, sprays, patches or cooling devices designed to manage hot flashes one week before and during the study.You have been vaccinated for COVID-19 within the past two weeks or have a current COVID-19 infection. You also cannot have ongoing symptoms related to COVID-19 that have lasted for at least two months and cannot be explained by another medical condition.You had surgery to treat obesity in the past.You are allergic to any of the study products or their ingredients.You possess sound health and are able to ingest the study product.You experienced menopause due to surgery, chemotherapy, radiation or medication.You have a history of drinking too much alcohol or using drugs.You are currently taking medication for menopausal symptoms or any other treatments listed in the study protocol.You have a history or current condition affecting your digestive system, liver, or kidneys that may prevent proper absorption, processing, or excretion of drugs.You have a history of heart, kidney or liver disease, or currently have an ongoing infection such as lyme disease, tuberculosis or HIV.You have had cancer (except for skin cancer that has not spread) in the last five years. Women who have had breast cancer, currently or in the past, will not be included.
- Group 1: Test Product: JDS-HF3.0 Capsules
- Group 2: Placebo Capsules
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this study open to adolescents below the age of twenty?
"Participants must be between 40 and 65 years of age to meet the qualifications for this trial."
Are there any requirements that preclude me from entering this trial?
"Recruitment for this trial is targeting 64 individuals between the ages of 40 and 65, who are suffering from hot flashes."
Is there still availability for individuals to join this clinical experiment?
"Indeed, clinicaltrials.gov displays that this medical trial is still open for recruitment and was first posted on May 1st 2023 with its latest update occurring on April 12th, 2023. The study is in need of 64 participants from 2 distinct sites."
To what extent is the enrollment for this trial open?
"Affirmative. The clinicaltrials.gov portal confirms that this research project, which was initially announced on May 1st 2023, is currently recruiting participants. Specifically, the team needs 64 individuals from 2 distinct medical institutions."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Altus Research: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger